Lumos Diagnostics Holdings Limited (LDXHF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 6.56 Million USD | 265.75% |
| 2023 | -4.28 Million USD | -196.1% |
| 2022 | 4.45 Million USD | 598.34% |
| 2021 | 638.08 Thousand USD | -74.54% |
| 2020 | 2.5 Million USD | 23.11% |
| 2019 | 2.03 Million USD | 143.0% |
| 2018 | 837.76 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | -3.63 Million USD | 15.17% |
| 2024 Q1 | 717.5 Thousand USD | 140.01% |
| 2024 Q2 | -3.52 Million USD | -591.37% |
| 2024 Q3 | 2.56 Million USD | 172.73% |
| 2024 Q4 | 2.56 Million USD | 0.0% |
| 2023 Q4 | -1.79 Million USD | -206.58% |
| 2023 FY | -4.28 Million USD | -196.1% |
| 2023 Q3 | 1.68 Million USD | 166.0% |
| 2023 Q2 | -2.54 Million USD | -316.69% |
| 2023 Q1 | 1.17 Million USD | 270.24% |
| 2022 Q4 | 317.76 Thousand USD | 0.0% |
| 2022 FY | 4.45 Million USD | 598.34% |
| 2022 Q2 | 1.29 Million USD | 0.0% |
| 2021 Q4 | 3.95 Million USD | 0.0% |
| 2021 Q2 | 4.82 Million USD | 0.0% |
| 2021 FY | 638.08 Thousand USD | -74.54% |
| 2020 Q2 | 1.08 Million USD | 0.0% |
| 2020 Q4 | 1.44 Million USD | 0.0% |
| 2020 FY | 2.5 Million USD | 23.11% |
| 2019 FY | 2.03 Million USD | 143.0% |
| 2018 FY | 837.76 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | 3500.518% |
| Arrayit Corporation | 2.57 Million USD | -154.868% |
| Atlantic International Corp. | -154.23 Thousand USD | 4355.223% |
| Biocept, Inc. | -2.58 Million USD | 354.183% |
| Bioqual, Inc. | 7.42 Million USD | 11.659% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 276 Thousand USD | -2277.899% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 99.903% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | -265.813% |
| iMD Companies, Inc. | -23.63 Thousand USD | 27865.791% |
| IDenta Corp. | 662.97 Thousand USD | -889.932% |
| Interpace Biosciences, Inc. | 23.04 Million USD | 71.518% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | -8360.636% |
| InVitro International | 635.98 Thousand USD | -931.943% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | -500.631% |
| NovelStem International Corp. | 12 Thousand USD | -54591.667% |
| Optigenex Inc. | -102.96 Thousand USD | 6473.949% |
| PharmChem, Inc. | 3.9 Million USD | -68.093% |
| Proteome Sciences plc | 2.09 Million USD | -213.026% |
| Response Genetics, Inc | 3.94 Million USD | -66.489% |
| Rennova Health, Inc. | 6.26 Million USD | -4.702% |
| RushNet, Inc. | 1.1 Million USD | -494.144% |
| ScreenPro Security Inc. | 856.57 Thousand USD | -666.192% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | 1725.523% |
| Todos Medical Ltd. | 4.31 Million USD | -52.274% |